Prognostic Factors for Clinical Outcome and Cartilage Regeneration after Implantation of Allogeneic Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Large-Sized Cartilage Defects with Osteoarthritis.

OBJECTIVE

To analyze the prognostic factors for clinical outcomes and cartilage regeneration after the implantation of allogeneic human umbilical cord blood mesenchymal stem cell (hUCB-MSC) for treating large-sized cartilage defects with osteoarthritis.

DESIGN

This study is a case-series with multiple subgroup analyses that divides the included patients into multiple subgroups based on various factors. Overall, 47 patients who underwent hUCB-MSC implantation were included. The patient-reported outcomes, magnetic resonance imaging (MRI), and second-look arthroscopy were used to assess the outcomes.

RESULTS

Combined realignment surgery significantly correlated with clinical outcomes, particularly pain. No other factors significantly influenced the clinical outcomes in short-term period. Subgroups with large defect sizes or meniscal insufficiency showed significantly poor MRI and arthroscopy outcomes (MRI, = 0.001, = 0.001; arthroscopy, = 0.032, = 0.042). The logistic regression showed that patients with a 1 cm larger defect size were 1.91 times less likely to achieve favorable MRI outcomes ( = 0.017; odds ratio [OR], 1.91). Cut-off value to predict the poor outcome was >5.7 cm (area under the curve, 0.756). A cartilage defect size >5.7 cm was the major poor prognostic factor for cartilage regeneration on MRI ( = 0.010; OR, 17.46). If the postoperative alignment shifted by 1° opposite to the cartilage defect, it was 1.4 times more likely to achieve favorable MRI outcomes ( = 0.028; OR, 1.4).

CONCLUSION

Combining realignment surgery showed a better prognosis for pain improvement. Cartilage defect size, meniscal function, and postoperative alignment are significant prognostic factors for cartilage regeneration. A cartilage defect size >5.7 cm was significantly related to poor cartilage regeneration.